96 related articles for article (PubMed ID: 23784787)
21. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease.
Cai Y; Liu S; Sothern RB; Xu S; Chan P
Eur J Neurol; 2010 Apr; 17(4):550-4. PubMed ID: 19912323
[TBL] [Abstract][Full Text] [Related]
22. Clock gene expression in the liver of streptozotocin-induced and spontaneous type 1 diabetic rats.
Hofmann K; Schönerstedt U; Mühlbauer E; Wedekind D; Peschke E
Horm Metab Res; 2013 Sep; 45(9):629-39. PubMed ID: 23632905
[TBL] [Abstract][Full Text] [Related]
23. Tumor-associated antigenic pattern in squamous cell carcinomas of the head and neck--analysed by SEREX.
Heubeck B; Wendler O; Bumm K; Schäfer R; Müller-Vogt U; Häusler M; Meese E; Iro H; Steinhart H
Eur J Cancer; 2013 Mar; 49(4):e1-7. PubMed ID: 16837193
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.
Van Herpen CM; Huijbens R; Looman M; De Vries J; Marres H; Van De Ven J; Hermsen R; Adema GJ; De Mulder PH
Clin Cancer Res; 2003 Aug; 9(8):2950-6. PubMed ID: 12912941
[TBL] [Abstract][Full Text] [Related]
25. Circadian clock gene expression is impaired in gestational diabetes mellitus.
Pappa KI; Gazouli M; Anastasiou E; Iliodromiti Z; Antsaklis A; Anagnou NP
Gynecol Endocrinol; 2013 Apr; 29(4):331-5. PubMed ID: 23323702
[TBL] [Abstract][Full Text] [Related]
26. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma.
Zhao N; Yang K; Yang G; Chen D; Tang H; Zhao D; Zhao C
PLoS One; 2013; 8(2):e55894. PubMed ID: 23405233
[TBL] [Abstract][Full Text] [Related]
28. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
29. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
[TBL] [Abstract][Full Text] [Related]
30. Human intestinal circadian clock: expression of clock genes in colonocytes lining the crypt.
Pardini L; Kaeffer B; Trubuil A; Bourreille A; Galmiche JP
Chronobiol Int; 2005; 22(6):951-61. PubMed ID: 16393700
[TBL] [Abstract][Full Text] [Related]
31. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
32. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.
Krugluger W; Brandstaetter A; Kállay E; Schueller J; Krexner E; Kriwanek S; Bonner E; Cross HS
Cancer Res; 2007 Aug; 67(16):7917-22. PubMed ID: 17699798
[TBL] [Abstract][Full Text] [Related]
33. [Effect of clock gene PER1 knockdown on clock gene networks in human oral squamous cell carcinoma].
Qin Z; Yiran A; Kai Y; Xiaoli S; Xiaoqiang L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Feb; 35(1):57-62. PubMed ID: 28326728
[TBL] [Abstract][Full Text] [Related]
34. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of serum amyloid A in head and neck squamous cell carcinoma.
Shinriki S; Ueda M; Ota K; Nakamura M; Kudo M; Ibusuki M; Kim J; Yoshitake Y; Fukuma D; Jono H; Kuratsu J; Shinohara M; Ando Y
J Oral Pathol Med; 2010 Jan; 39(1):41-7. PubMed ID: 19453393
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
37. Temporal dynamics of mouse hippocampal clock gene expression support memory processing.
Jilg A; Lesny S; Peruzki N; Schwegler H; Selbach O; Dehghani F; Stehle JH
Hippocampus; 2010 Mar; 20(3):377-88. PubMed ID: 19437502
[TBL] [Abstract][Full Text] [Related]
38. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
[TBL] [Abstract][Full Text] [Related]
39. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
40. Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Pradhan-Palikhe P; Vesterinen T; Tarkkanen J; Leivo I; Sorsa T; Salo T; Mattila PS
Oral Oncol; 2010 Jul; 46(7):514-8. PubMed ID: 20371206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
